Send to

Choose Destination
See comment in PubMed Commons below
Neurology. 2003 Nov 25;61(10):1418-20.

The effects of pramipexole in REM sleep behavior disorder.

Author information

  • 1Centre d'étude du sommeil et des rythmes biologiques, Hôpital du Sacré-Coeur, Montréal, Canada.


The authors evaluated the effects of pramipexole, a dopaminergic D2-D3 receptor agonist, on eight patients with idiopathic REM sleep behavior disorder. Five patients reported a sustained reduction in the frequency or intensity of sleep motor behaviors, which was confirmed by video recording, although no change was observed for the percentage of phasic EMG activity during REM sleep. Surprisingly, a decrease in the percentage of time spent with REM sleep muscle atonia was observed with treatment. The treatment did not modify the indexes of periodic leg movements.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center